This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, Y.
Right arrow Articles by Rollins, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, Y.
Right arrow Articles by Rollins, B. J.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 09 1995, 4851-4855, Vol 15, No. 9
Copyright © 1995, American Society for Microbiology

A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer

Y Zhang and BJ Rollins
Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

Monocyte chemoattractant protein 1 (MCP-1) is a member of the chemokine family of proinflammatory cytokines, all of which share a high degree of amino acid sequence similarity. Aberrant expression of chemokines occurs in a variety of diseases that have an inflammatory component, such as atherosclerosis. Although structural analyses indicate that chemokines form homodimers, there is controversy about whether dimerization is necessary for activity. To address this question for MCP-1, we obtained evidence in four steps. First, coprecipitation experiments demonstrated that MCP-1 forms dimers at physiological concentrations. Second, chemically cross-linked MCP-1 dimers attract monocytes in vitro with a 50% effective concentration of 400 pM, identical to the activity of non-cross-linked MCP-1. Third, an N- terminal deletion variant of MCP-1 (called 7ND) that inhibits MCP-1- mediated monocyte chemotaxis specifically forms heterodimers with wild- type MCP-1. Finally, although 7ND inhibits wild-type MCP-1 activity, it has no effect on cross-linked MCP-1. These results indicate that 7ND is a dominant negative inhibitor, implying that MCP-1 activates its receptor as a dimer. In addition, chemical cross-linking restores activity to an inactive N-terminal insertional variant of MCP-1, further supporting the need for dimerization. Since the reported Kd for MCP-1 monomer dissociation is much higher than its 50% effective concentration or Kd for receptor binding, active dimer formation may require high local concentrations of MCP-1. Our data further suggest that the dimer interface can be a target for MCP-1 inhibitory drugs.


This article has been cited by other articles:

  • Sell, H., Laurencikiene, J., Taube, A., Eckardt, K., Cramer, A., Horrighs, A., Arner, P., Eckel, J. (2009). Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle Cells. Diabetes 58: 2731-2740 [Abstract] [Full Text]  
  • Popivanova, B. K., Kostadinova, F. I., Furuichi, K., Shamekh, M. M., Kondo, T., Wada, T., Egashira, K., Mukaida, N. (2009). Blockade of a Chemokine, CCL2, Reduces Chronic Colitis-Associated Carcinogenesis in Mice. Cancer Res. 69: 7884-7892 [Abstract] [Full Text]  
  • Fu, Z., Wang, M., Gucek, M., Zhang, J., Wu, J., Jiang, L., Monticone, R. E., Khazan, B., Telljohann, R., Mattison, J., Sheng, S., Cole, R. N., Spinetti, G., Pintus, G., Liu, L., Kolodgie, F. D., Virmani, R., Spurgeon, H., Ingram, D. K., Everett, A. D., Lakatta, E. G., Van Eyk, J. E. (2009). Milk Fat Globule Protein Epidermal Growth Factor-8: A Pivotal Relay Element Within the Angiotensin II and Monocyte Chemoattractant Protein-1 Signaling Cascade Mediating Vascular Smooth Muscle Cells Invasion. Circ. Res. 104: 1337-1346 [Abstract] [Full Text]  
  • Hall, S. E., Mao, A., Nicolaidou, V., Finelli, M., Wise, E. L., Nedjai, B., Kanjanapangka, J., Harirchian, P., Chen, D., Selchau, V., Ribeiro, S., Schyler, S., Pease, J. E., Horuk, R., Vaidehi, N. (2009). Elucidation of Binding Sites of Dual Antagonists in the Human Chemokine Receptors CCR2 and CCR5. Mol. Pharmacol. 75: 1325-1336 [Abstract] [Full Text]  
  • Handel, T. M., Johnson, Z., Rodrigues, D. H., dos Santos, A. C., Cirillo, R., Muzio, V., Riva, S., Mack, M., Deruaz, M., Borlat, F., Vitte, P.-A., Wells, T. N. C., Teixeira, M. M., Proudfoot, A. E. I. (2008). An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo. J. Leukoc. Biol. 84: 1101-1108 [Abstract] [Full Text]  
  • Yoshimura, T., Oppenheim, J. J. (2008). Chemerin reveals its chimeric nature. JEM 205: 2187-2190 [Abstract] [Full Text]  
  • Hori, M., Nobe, H., Horiguchi, K., Ozaki, H. (2008). MCP-1 targeting inhibits muscularis macrophage recruitment and intestinal smooth muscle dysfunction in colonic inflammation. Am. J. Physiol. Cell Physiol. 294: C391-C401 [Abstract] [Full Text]  
  • Jin, H., Shen, X., Baggett, B. R., Kong, X., LiWang, P. J. (2007). The Human CC Chemokine MIP-1beta Dimer Is Not Competent to Bind to the CCR5 Receptor. J. Biol. Chem. 282: 27976-27983 [Abstract] [Full Text]  
  • Fredriksen, A. B., Bogen, B. (2007). Chemokine-idiotype fusion DNA vaccines are potentiated by bivalency and xenogeneic sequences. Blood 110: 1797-1805 [Abstract] [Full Text]  
  • Zhao, H F, Ito, T, Gibo, J, Kawabe, K, Oono, T, Kaku, T, Arita, Y, Zhao, Q W, Usui, M, Egashira, K, Nawata, H (2005). Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats. Gut 54: 1759-1767 [Abstract] [Full Text]  
  • Marra, F (2005). Renaming cytokines: MCP-1, Major Chemokine in Pancreatitis. Gut 54: 1679-1681 [Full Text]  
  • Goser, S., Ottl;, R., Brodner, A., Dengler, T. J., Torzewski, J., Egashira, K., Rose, N. R., Katus, H. A., Kaya, Z. (2005). Critical Role for Monocyte Chemoattractant Protein-1 and Macrophage Inflammatory Protein-1{alpha} in Induction of Experimental Autoimmune Myocarditis and Effective Anti-Monocyte Chemoattractant Protein-1 Gene Therapy. Circulation 112: 3400-3407 [Abstract] [Full Text]  
  • Levitin, F., Baruch, A., Weiss, M., Stiegman, K., Hartmann, M.-l., Yoeli-Lerner, M., Ziv, R., Zrihan-Licht, S., Shina, S., Gat, A., Lifschitz, B., Simha, M., Stadler, Y., Cholostoy, A., Gil, B., Greaves, D., Keydar, I., Zaretsky, J., Smorodinsky, N., Wreschner, D. H. (2005). A Novel Protein Derived from the MUC1 Gene by Alternative Splicing and Frameshifting. J. Biol. Chem. 280: 10655-10663 [Abstract] [Full Text]  
  • Kyriakides, T. R., Foster, M. J., Keeney, G. E., Tsai, A., Giachelli, C. M., Clark-Lewis, I., Rollins, B. J., Bornstein, P. (2004). The CC Chemokine Ligand, CCL2/MCP1, Participates in Macrophage Fusion and Foreign Body Giant Cell Formation. Am. J. Pathol. 165: 2157-2166 [Abstract] [Full Text]  
  • Saiura, A., Sata, M., Hiasa, K.-i., Kitamoto, S., Washida, M., Egashira, K., Nagai, R., Makuuchi, M. (2004). Antimonocyte Chemoattractant Protein-1 Gene Therapy Attenuates Graft Vasculopathy. Arterioscler. Thromb. Vasc. Bio. 24: 1886-1890 [Abstract] [Full Text]  
  • Shimizu, S., Nakashima, H., Masutani, K., Inoue, Y., Miyake, K., Akahoshi, M., Tanaka, Y., Egashira, K., Hirakata, H., Otsuka, T., Harada, M. (2004). Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice. Rheumatology (Oxford) 43: 1121-1128 [Abstract] [Full Text]  
  • Ali, M. H., Peisach, E., Allen, K. N., Imperiali, B. (2004). X-ray structure analysis of a designed oligomeric miniprotein reveals a discrete quaternary architecture. Proc. Natl. Acad. Sci. USA 101: 12183-12188 [Abstract] [Full Text]  
  • Niiyama, H., Kai, H., Yamamoto, T., Shimada, T., Sasaki, K.-I., Murohara, T., Egashira, K., Imaizumi, T. (2004). Roles of endogenous monocyte chemoattractant protein-1 in ischemia-induced neovascularization. J Am Coll Cardiol 44: 661-666 [Abstract] [Full Text]  
  • Schecter, A. D., Berman, A. B., Yi, L., Ma, H., Daly, C. M., Soejima, K., Rollins, B. J., Charo, I. F., Taubman, M. B. (2004). MCP-1-dependent signaling in CCR2-/- aortic smooth muscle cells. J. Leukoc. Biol. 75: 1079-1085 [Abstract] [Full Text]  
  • Inoshima, I., Kuwano, K., Hamada, N., Hagimoto, N., Yoshimi, M., Maeyama, T., Takeshita, A., Kitamoto, S., Egashira, K., Hara, N. (2004). Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L1038-L1044 [Abstract] [Full Text]  
  • Wada, T., Furuichi, K., Sakai, N., Iwata, Y., Kitagawa, K., Ishida, Y., Kondo, T., Hashimoto, H., Ishiwata, Y., Mukaida, N., Tomosugi, N., Matsushima, K., Egashira, K., Yokoyama, H. (2004). Gene Therapy via Blockade of Monocyte Chemoattractant Protein-1 for Renal Fibrosis. J. Am. Soc. Nephrol. 15: 940-948 [Abstract] [Full Text]  
  • Kajihara, N., Morita, S., Nishida, T., Tatewaki, H., Eto, M., Egashira, K., Yasui, H. (2003). Transfection With a Dominant-Negative Inhibitor of Monocyte Chemoattractant Protein-1 Gene Improves Cardiac Function After 6 Hours of Cold Preservation. Circulation 108: II-213-218 [Abstract] [Full Text]  
  • Shimizu, H., Maruyama, S., Yuzawa, Y., Kato, T., Miki, Y., Suzuki, S., Sato, W., Morita, Y., Maruyama, H., Egashira, K., Matsuo, S. (2003). Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Renal Injury Induced by Protein-Overload Proteinuria. J. Am. Soc. Nephrol. 14: 1496-1505 [Abstract] [Full Text]  
  • Furuichi, K., Wada, T., Iwata, Y., Kitagawa, K., Kobayashi, K.-i., Hashimoto, H., Ishiwata, Y., Tomosugi, N., Mukaida, N., Matsushima, K., Egashira, K., Yokoyama, H. (2003). Gene Therapy Expressing Amino-Terminal Truncated Monocyte Chemoattractant Protein-1 Prevents Renal Ischemia-Reperfusion Injury. J. Am. Soc. Nephrol. 14: 1066-1071 [Abstract] [Full Text]  
  • Egashira, K. (2003). Molecular Mechanisms Mediating Inflammation in Vascular Disease: Special Reference to Monocyte Chemoattractant Protein-1. Hypertension 41: 834-841 [Abstract] [Full Text]  
  • Inoue, S., Egashira, K., Ni, W., Kitamoto, S., Usui, M., Otani, K., Ishibashi, M., Hiasa, K.-i., Nishida, K.-i., Takeshita, A. (2002). Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Limits Progression and Destabilization of Established Atherosclerosis in Apolipoprotein E-Knockout Mice. Circulation 106: 2700-2706 [Abstract] [Full Text]  
  • Ikeda, Y., Yonemitsu, Y., Kataoka, C., Kitamoto, S., Yamaoka, T., Nishida, K.-I., Takeshita, A., Egashira, K., Sueishi, K. (2002). Anti-monocyte chemoattractant protein-1 gene therapy attenuates pulmonary hypertension in rats. Am. J. Physiol. Heart Circ. Physiol. 283: H2021-H2028 [Abstract] [Full Text]  
  • Egashira, K., Zhao, Q., Kataoka, C., Ohtani, K., Usui, M., Charo, I. F., Nishida, K.-i., Inoue, S., Katoh, M., Ichiki, T., Takeshita, A. (2002). Importance of Monocyte Chemoattractant Protein-1 Pathway in Neointimal Hyperplasia After Periarterial Injury in Mice and Monkeys. Circ. Res. 90: 1167-1172 [Abstract] [Full Text]  
  • Kuloglu, E. S., McCaslin, D. R., Markley, J. L., Volkman, B. F. (2002). Structural Rearrangement of Human Lymphotactin, a C Chemokine, under Physiological Solution Conditions. J. Biol. Chem. 277: 17863-17870 [Abstract] [Full Text]  
  • Seet, B. T., Singh, R., Paavola, C., Lau, E. K., Handel, T. M., McFadden, G. (2001). Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc. Natl. Acad. Sci. USA 10.1073/pnas.171069398v1 [Abstract] [Full Text]  
  • Ni, W., Egashira, K., Kitamoto, S., Kataoka, C., Koyanagi, M., Inoue, S., Imaizumi, K., Akiyama, C., Nishida, K.-i., Takeshita, A. (2001). New Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Atherosclerosis in Apolipoprotein E-Knockout Mice. Circulation 103: 2096-2101 [Abstract] [Full Text]  
  • Godaly, G., Hang, L., Frendeus, B., Svanborg, C. (2000). Transepithelial Neutrophil Migration Is CXCR1 Dependent In Vitro and Is Defective in IL-8 Receptor Knockout Mice. J. Immunol. 165: 5287-5294 [Abstract] [Full Text]  
  • EGASHIRA, K., KOYANAGI, M., KITAMOTO, S., NI, W., KATAOKA, C., MORISHITA, R., KANEDA, Y., AKIYAMA, C., NISHIDA, K.-I., SUEISHI, K., TAKESHITA, A. (2000). Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis. FASEB J. 14: 1974-1978 [Abstract] [Full Text]  
  • Proudfoot, A. E. I., Buser, R., Borlat, F., Alouani, S., Soler, D., Offord, R. E., Schroder, J.-M., Power, C. A., Wells, T. N. C. (1999). Amino-terminally Modified RANTES Analogues Demonstrate Differential Effects on RANTES Receptors. J. Biol. Chem. 274: 32478-32485 [Abstract] [Full Text]  
  • Czaplewski, L. G., McKeating, J., Craven, C. J., Higgins, L. D., Appay, V., Brown, A., Dudgeon, T., Howard, L. A., Meyers, T., Owen, J., Palan, S. R., Tan, P., Wilson, G., Woods, N. R., Heyworth, C. M., Lord, B. I., Brotherton, D., Christison, R., Craig, S., Cribbes, S., Edwards, R. M., Evans, S. J., Gilbert, R., Morgan, P., Randle, E., Schofield, N., Varley, P. G., Fisher, J., Waltho, J. P., Hunter, M. G. (1999). Identification of Amino Acid Residues Critical for Aggregation of Human CC Chemokines Macrophage Inflammatory Protein (MIP)-1alpha , MIP-1beta , and RANTES. CHARACTERIZATION OF ACTIVE DISAGGREGATED CHEMOKINE VARIANTS. J. Biol. Chem. 274: 16077-16084 [Abstract] [Full Text]  
  • Paavola, C. D., Hemmerich, S., Grunberger, D., Polsky, I., Bloom, A., Freedman, R., Mulkins, M., Bhakta, S., McCarley, D., Wiesent, L., Wong, B., Jarnagin, K., Handel, T. M. (1998). Monomeric Monocyte Chemoattractant Protein-1 (MCP-1) Binds and Activates the MCP-1 Receptor CCR2B. J. Biol. Chem. 273: 33157-33165 [Abstract] [Full Text]  
  • Rollins, B. J. (1997). Chemokines. Blood 90: 909-928 [Full Text]  
  • Tangirala, R. K., Murao, K., Quehenberger, O. (1997). Regulation of Expression of the Human Monocyte Chemotactic Protein-1 Receptor (hCCR2) by Cytokines. J. Biol. Chem. 272: 8050-8056 [Abstract] [Full Text]  
  • Proudfoot, A. E. I., Power, C. A., Hoogewerf, A. J., Montjovent, M.-O., Borlat, F., Offord, R. E., Wells, T. N. C. (1996). Extension of Recombinant Human RANTES by the Retention of the Initiating Methionine Produces a Potent Antagonist. J. Biol. Chem. 271: 2599-2603 [Abstract] [Full Text]  
  • Guan, E., Wang, J., Norcross, M. A. (2001). Identification of Human Macrophage Inflammatory Proteins 1alpha and 1beta as a Native Secreted Heterodimer. J. Biol. Chem. 276: 12404-12409 [Abstract] [Full Text]  
  • Seet, B. T., Singh, R., Paavola, C., Lau, E. K., Handel, T. M., McFadden, G. (2001). Molecular determinants for CC-chemokine recognition by a poxvirus CC-chemokine inhibitor. Proc. Natl. Acad. Sci. USA 98: 9008-9013 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»